After 2.5 years studying pet meds market, FTC calls … drumroll … for more study

DVM360 Magazine

Report presents misguided conclusions but does not demand federal legislation mandating veterinary prescriptions.

Cushing_logo_new

Report presents misguided conclusions but does not demand federal legislation mandating veterinary prescriptions.

On May 27 the U.S. Federal Trade Commission (FTC) finally issued its report on pet medications stemming from its Oct. 4, 2012, workshop on the topic in Washington, D.C. Industry observers and participants (including this blogger) have been waiting for 30-plus months to hear what the FTC had to say, and now we know. I will write about this flawed report in more depth in coming weeks, but let me set the stage for dvm360 readers at the grass-tops level, not down in the policy weeds.

First and foremost, the FTC did not come out with guns blazing and call for federal legislation. This had to disappoint critics of the veterinary profession and those lobbying for the latest versions of bills in Congress demanding portable prescriptions for every veterinary drug prescribed. These bills have generated virtually no interest in the U.S. House or Senate since they were first introduced back in 2010, and their advocates keenly waited for an FTC report that could pump some fuel into the legislative engine. That did not happen with this report.

Read Full Article

Categorized: Posts from Mark